×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not ...
ConchoValleyHomepage.com
Ruling removes potential complications for manufacturing, pre-clinical development, IND submission, clinical development, and ultimately...
1 week ago
Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
Yahoo Finance
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
3 months ago
Mira Pharmaceuticals CEO Erez Aminov buys $8,176 in company stock By Investing.com
Investing.com
Erez Aminov, the Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), has recently purchased shares of the company's common...
2 weeks ago
Insiders Who Sold MIRA Pharmaceuticals Missed Out On 19% Stock Increase
Simply Wall Street
While it's been a great week for MIRA Pharmaceuticals, Inc. ( NASDAQ:MIRA ) shareholders after stock gained 19%, not so...
2 weeks ago
MIRA Pharmaceuticals Board Revamp and Strategic Advisory Hire - TipRanks.com
Tipranks
MIRA Pharmaceuticals, Inc. (MIRA) has shared an announcement. Mira Pharmaceuticals, Inc. has undergone a significant board reshuffle to enhance scientific...
2 months ago
Why Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today?
InvestorPlace
Mira Pharmaceuticals stock is rising higher on Friday after the company updated MIRA investors on its discovery of a new molecule.
2 months ago
MIRA, MIRALOGX sign agreement for depression therapy
Pharmaceutical Technology
MIRA Pharmaceuticals has signed a licencing agreement with MIRALOGX for the development and marketing of Ketamir-2 for depressive disorders.
6 months ago
Following the legalization of recreational cannabis, MIRA Pharmaceuticals moves to go public
Technical.ly
Baltimore's own MIRA Pharmaceuticals, still riding high on the nearly $7 million seed it raised in 2022, is ready to dance with the bulls...
10 months ago
MIRA Stock Price and Chart — NASDAQ:MIRA — TradingView
TradingView
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate,...
10 months ago
DEA clears MIRA-55 for further development By Investing.com
Investing.com
MIAMI - MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical stage pharmaceutical company, received a favorable ruling from the U.S....
1 week ago